Last reviewed 2026-06-01 · How we verify

Baycol (CERIVASTATIN)

Bayer · FDA-approved withdrawn Small molecule Under review Quality 40/100

Baycol (generic name: CERIVASTATIN) is a cerivastatin Small molecule drug developed by Bayer. It is currently FDA-approved (first approved 1997) for Hypercholesterolemia, Mixed hyperlipidemia.

Baycol, a small molecule, was studied for pain management in clinical trials, including a comparison of its analgesic effect in adductor canal block after total knee replacement using different administration methods.

At a glance

Generic name	CERIVASTATIN
Sponsor	Bayer
Drug class	cerivastatin
Target	3-hydroxy-3-methylglutaryl-coenzyme A reductase
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved
First approval	1997

Approved indications

Hypercholesterolemia
Mixed hyperlipidemia

Common side effects

No common side effects on file.

Drug interactions

ciclosporin
clarithromycin
erythromycin
fosamprenavir
gemfibrozil
indinavir
itraconazole
nefazodone
nelfinavir
nicotinic acid
rifabutin
ritonavir

Key clinical trials

Adductor Canal Block After Total Knee Replacement - a Suture-method Catheter vs a Standard Catheter vs a Single Bolus (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Baycol CI brief — competitive landscape report
Baycol updates RSS · CI watch RSS
Bayer portfolio CI

Frequently asked questions about Baycol

What is Baycol?

Baycol (CERIVASTATIN) is a cerivastatin drug developed by Bayer, indicated for Hypercholesterolemia, Mixed hyperlipidemia.

What is Baycol used for?

Baycol is indicated for Hypercholesterolemia, Mixed hyperlipidemia.

Who makes Baycol?

Baycol is developed and marketed by Bayer (see full Bayer pipeline at /company/bayer).

What is the generic name of Baycol?

CERIVASTATIN is the generic (nonproprietary) name of Baycol.

What drug class is Baycol in?

Baycol belongs to the cerivastatin class. See all cerivastatin drugs at /class/cerivastatin.

When was Baycol approved?

Baycol was first approved on 1997.

What development phase is Baycol in?

Baycol is FDA-approved (marketed).

What does Baycol target?

Baycol targets 3-hydroxy-3-methylglutaryl-coenzyme A reductase and is a cerivastatin.

Drug class: All cerivastatin drugs
Target: All drugs targeting 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Manufacturer: Bayer — full pipeline
Therapeutic area: All drugs in Metabolic
Indication: Drugs for Hypercholesterolemia
Indication: Drugs for Mixed hyperlipidemia

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing